These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18378908)

  • 21. Pseudotyping of HIV-1 with Human T-Lymphotropic Virus 1 (HTLV-1) Envelope Glycoprotein during HIV-1-HTLV-1 Coinfection Facilitates Direct HIV-1 Infection of Female Genital Epithelial Cells: Implications for Sexual Transmission of HIV-1.
    Tang Y; George AM; Petrechko O; Nouvet FJ; Sweet SD; Tanaka Y; Imbiakha BS; Jiang G; Gao W; Anastos K; Hildreth JEK
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29624497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells.
    VanCompernolle SE; Taylor RJ; Oswald-Richter K; Jiang J; Youree BE; Bowie JH; Tyler MJ; Conlon JM; Wade D; Aiken C; Dermody TS; KewalRamani VN; Rollins-Smith LA; Unutmaz D
    J Virol; 2005 Sep; 79(18):11598-606. PubMed ID: 16140737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preferential infection of dendritic cells during human immunodeficiency virus type 1 infection of blood leukocytes.
    Cameron PU; Handley AJ; Baylis DC; Solomon AE; Bernard N; Purcell DF; Lewin SR
    J Virol; 2007 Mar; 81(5):2297-306. PubMed ID: 17166903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myeloid Cells in Intact Human Cervical Explants Capture HIV and Can Transmit It to CD4 T Cells.
    Trifonova RT; Bollman B; Barteneva NS; Lieberman J
    Front Immunol; 2018; 9():2719. PubMed ID: 30532754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and crystallization of NS5A domain I of hepatitis C virus.
    Marcotrigiano J; Tellinghuisen T
    Methods Mol Biol; 2009; 510():85-94. PubMed ID: 19009255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A.
    He Y; Tan SL; Tareen SU; Vijaysri S; Langland JO; Jacobs BL; Katze MG
    J Virol; 2001 Jun; 75(11):5090-8. PubMed ID: 11333890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal tissue tropism and dissemination of HIV-1 subtype B acute envelope-expressing chimeric virus.
    King DF; Siddiqui AA; Buffa V; Fischetti L; Gao Y; Stieh D; McKay PF; Rogers P; Ochsenbauer C; Kappes JC; Arts EJ; Shattock RJ
    J Virol; 2013 Jan; 87(2):890-9. PubMed ID: 23135721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of human immune deficiency virus infection on hepatitis C virus infection and replication.
    Parodi C; Belmonte L; Baré P; de Bracco MM; Ruibal-Ares B
    Curr HIV Res; 2007 Jan; 5(1):55-67. PubMed ID: 17266557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inefficient HIV-1
    DeLucia DC; Rinaldo CR; Rappocciolo G
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infection.
    Frank I; Robbiani M
    J Acquir Immune Defic Syndr; 2011 Mar; 56(3):204-12. PubMed ID: 21084994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid droplet-binding protein TIP47 regulates hepatitis C Virus RNA replication through interaction with the viral NS5A protein.
    Vogt DA; Camus G; Herker E; Webster BR; Tsou CL; Greene WC; Yen TS; Ott M
    PLoS Pathog; 2013; 9(4):e1003302. PubMed ID: 23593007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Function follows form: the structure of the N-terminal domain of HCV NS5A.
    Moradpour D; Brass V; Penin F
    Hepatology; 2005 Sep; 42(3):732-5. PubMed ID: 16116650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
    Cheeseman HM; Olejniczak NJ; Rogers PM; Evans AB; King DFL; Ziprin P; Liao HX; Haynes BF; Shattock RJ
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells.
    Xiang J; McLinden JH; Rydze RA; Chang Q; Kaufman TM; Klinzman D; Stapleton JT
    J Immunol; 2009 Dec; 183(12):7860-9. PubMed ID: 19923460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling HIV transfer between dendritic cells and T cells: importance of HIV phenotype, dendritic cell-T cell contact and T-cell activation.
    Vanham G; Penne L; Allemeersch H; Kestens L; Willems B; van der Groen G; Jeang KT; Toossi Z; Rich E
    AIDS; 2000 Oct; 14(15):2299-311. PubMed ID: 11089618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a peptide domain within the GB virus C NS5A phosphoprotein that inhibits HIV replication.
    Xiang J; McLinden JH; Chang Q; Jordan EL; Stapleton JT
    PLoS One; 2008 Jul; 3(7):e2580. PubMed ID: 18596910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication.
    Elazar M; Cheong KH; Liu P; Greenberg HB; Rice CM; Glenn JS
    J Virol; 2003 May; 77(10):6055-61. PubMed ID: 12719597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular ATP reduces HIV-1 transfer from immature dendritic cells to CD4+ T lymphocytes.
    Barat C; Gilbert C; Imbeault M; Tremblay MJ
    Retrovirology; 2008 Mar; 5():30. PubMed ID: 18373845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection.
    Terrazas-Aranda K; Van Herrewege Y; Hazuda D; Lewi P; Costi R; Di Santo R; Cara A; Vanham G
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2544-54. PubMed ID: 18474579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.